Solveig Tangedal's picture

Solveig Tangedal

PhD Candidate
  • E-mailsolveig.tangedal@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2022). The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis. Microbiome. 11 pages.
  • Show author(s) (2022). The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease . PLOS ONE.
  • Show author(s) (2022). A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease. PLOS ONE. 15 pages.
  • Show author(s) (2020). The airway microbiota and exacerbations of COPD. European Respiratory Journal Open Research (ERJ Open Research). 1-10.
  • Show author(s) (2019). Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLOS ONE. 1-18.
  • Show author(s) (2017). Protected sampling is preferable in bronchoscopic studies of the airway microbiome. European Respiratory Journal Open Research (ERJ Open Research).
  • Show author(s) (2017). Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respiratory Research. 1-9.
  • Show author(s) (2014). Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respiratory Research.
  • Show author(s) (2019). Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. European Respiratory Journal.
  • Show author(s) (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.

More information in national current research information system (CRIStin)